Newsletter | November 18, 2026

11.18.26 -- Developing Your Vapor Phase Hydrogen Peroxide Cycle

SPONSOR

Optimizing Antibody Polishing with Mixed-Mode Chromatography

Efficient mAb polishing requires balancing impurity clearance with product recovery. See how a DoE-guided approach optimized a weak anion exchange hydrophobic interaction chromatography (AEX-HIC) mixed-mode resin for aggregate removal in flow-through mode, reducing high molecular weight species from 7.3% to 0.7% while achieving 85% mAb monomer recovery. Learn how this experimental approach can help scientists and engineers define operating conditions and evaluate polishing performance using measurable process outcomes.

FOCUS ON DOWNSTREAM MANUFACTURING

Developing Your Vapor Phase Hydrogen Peroxide Cycle

Vapor phase hydrogen peroxide has been used for decades as a surface decontaminant in pharma/biotech, but there has been little guidance on how to establish the parameters. Here's an industry consensus from BioPhorum.

Rapid Process Development For Cell Line Optimization Using Protein A

Rapidly purify 24 monoclonal antibody samples in under eight hours with a membrane-based affinity capture that streamlines cell line optimization and accelerates early-stage bioprocess development.

Best Practices For Chromatography Column Packing

Proper packing for resin is crucial to prevent issues like cracking or channeling which can lead to process disruptions and product loss.

Denaturing SEC-MS Analysis Of High Molecular Weight Impurities

Look at how denaturing SEC‑MS uncovers low‑level oligomers and truncated variants in GLP‑1 peptides, offering clarity on impurity profiles and supporting confident assessment of molecular integrity.

Reducing Costs And Improving Efficiency

Transform your downstream workflow with modernize bioprocessing by optimizing bed height and resin selection. Improve productivity and HCP clearance while reducing costs.

GMP Reagent Enables Improvement In MSC-EV Processing Recovery

Filter fouling during EV purification can eliminate over 95% of your starting material. See how a novel GMP-compatible reagent changes the recovery equation entirely.

Connecting Oligonucleotide R&D With Early Clinical Scale Manufacturing

Watch to learn about practical considerations that can support a smoother transition from oligonucleotide R&D to early clinical-scale manufacturing.

DOWNSTREAM MANUFACTURING SOLUTIONS

•

Go Further In GLP-1 Analogue Manufacturing - MilliporeSigma

•

Zero Time To Master: Uniform Seals - Nordson MEDICAL

•

Prepacked Process-Scale Columns Packed With Bio-Rad Chromatography Resins - Bio-Rad Laboratories, Inc.

•

Single-Use Liquid Chromatography System - Cytiva

FOCUS ON FILL-FINISH

A Hotbed For Life Sciences: Middlesex County's Unique Value Proposition

Middlesex County, NJ, is a hotbed for the life sciences, offering a deep talent pool, an extensive R&D presence, and dedicated backing by local government in the form of strategic investment.

Scaling Manufacturing Flexibility For Fill-Finish Commercial Success

Pharma and biotech developers rely on adaptable fill‑finish capacity to meet evolving market demands, scale products from clinical to commercial, and respond rapidly to public‑health emergencies.

Reducing Fill Risk In Drug Product Manufacture

How robotic, gloveless fill‑finish cuts aseptic risk, enables flexible containers, and scales manufacturing—connecting advanced automation to patient safety and operational efficiency.

What Sterile Injectable Sponsors Need To Know

Late-stage sterile injectable manufacturing demands balancing compliance, capacity, and complexity. Early investment in validated systems streamlines scale-up and launch.

Inside Modern Fill-Finish Technology For Biologics

Emerging fill-finish technologies improve sterility, quality control, and flexibility while enabling prefilled systems and biologics scale-up.

FILL-FINISH SOLUTIONS

•

Enzyme Indicator Technology - Protak Scientific Ltd

•

Environmental Monitoring For Aseptic Filling Operations - AST

Connect With Bioprocess Online: